Follow up was halted in 55.9% of those on tirzepatide and 52.5% on semaglutide
In animal and human studies, pure GIP protocols model glucose spikes and fat accumulation
Discussion This study demonstrates that newer anti-obesity medications, particularly Tirzepatide and Semaglutide, show superior ocular safety profiles relative to traditional agents like Phentermine/Topiramate, Naltrexone/Bupropion, and Phentermine in people with obesity
From the incretin concept and the discovery of glp-1 to today's diabetes therapy
Medication Review: Sometimes, anticoagulants (blood thinners) must be stopped, as they can prevent the protective clots over plaques from healing
Weight Loss $299$449 Per Month (by dose) weekly Injection FDA Approved FDA Approved Clinically Proven 22% Avg